|
Delayed
Nasdaq
10:45:57 29/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 10.54 USD | -0.72% |
|
+0.99% | +71.43% |
| 13/10 | ImmuCell Q3 Preliminary Sales Rise | MT |
| 13/10 | Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | -0.72% | +0.99% | +71.43% | +74.85% | +19.81% | 9.65Cr |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
